12:00 AM
 | 
May 07, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zohydro hydrocodone bitartrate regulatory update

Zogenix submitted an NDA to FDA for Zohydro hydrocodone bitartrate to treat chronic pain. The oral controlled-release formulation of hydrocodone uses Spheroidal...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >